Frequency and Pattern of Dyslipidaemia in Pakistani Females with Coronary Artery Disease

Frequency and Pattern of Dyslipidaemia in Pakistani Females with Coronary Artery Disease

Objective: To determine the frequency and pattern of lipid abnormalities in diagnosed female patients of coronary artery disease in a tertiary care hospital of Karachi. Methods: This cross-sectional study was conducted from January 2016 to August 2016. A total of 300 female patients of C...

Full description

Bibliographic Details
Main Authors:	Shazia Nazar, Ambreen Qamar, Hira Ahmed, Shazia Fahmi, Afshan Mehboob, Wajiha Iffat
Format:	Article
Language:	English
Published:	KARACHI MEDICAL AND DENTAL COLLEGE 2019-06-01
Series:	Annals of Abbasi Shaheed Hospital and Karachi Medical & Dental College
Subjects:	Coronary artery disease, dyslipidaemias, cholesterol.
Online Access:	https://www.annals-ashkmdc.org/index.php/ashkmdc/article/view/32

Similar Items

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal
by: Ana Catarina Alves, et al.
Published: (2023-04-01)

Prevalence of dyslipidaemia among diabetic patients at the Namibia Institute of Pathology, Windhoek
by: Sylvia N. Alweendo, et al.
Published: (2023-07-01)

Patterns of Dyslipidaemia in Prehypertensive and Normotensive Subjects
by: Usman Wali
Published: (2015-03-01)

Association of Serum Vitamin-D and Omentin-1 Levels in Post- Menopausal Female with Coronary Artery Disease
by: Shazia Nazar, et al.
Published: (2020-09-01)

A study of dyslipidaemia among patients with type 2 diabetes in the Northern Province of Sri Lanka
by: N. Suganthan, et al.
Published: (2016-08-01)

Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
by: Peter E. Penson, et al.
Published: (2021-08-01)

Dyslipidaemia in Newly Diagnosed Diabetic Patients with and without Microalbuminuria
by: Iffat Sultana, Muhammad Farooq, Aamir Shahzad, Asim Zulfiqar, Shayan, Mohammad Masood Savul
Published: (2014-12-01)

European guidelines for the treatment of dyslipidaemias: New concepts and future challenges
by: Angela Pirillo, et al.
Published: (2023-10-01)

Advances on the treatment of Dyslipidaemias
by: Eleni Bilianou
Published: (2017-01-01)

The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study
by: Sylvester Yao Lokpo, et al.
Published: (2022-08-01)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
by: Giuseppe Banderali, et al.
Published: (2022-01-01)

Dislipidemia en personas mayores de 60 años Dyslipidaemia in persons over 60
Published: (2005-08-01)

Updated management of dyslipidaemia in diabetes: A new step towards more stringent targets
by: Louis Monnier, et al.
Published: (2021-01-01)

Treatment of Dyslipidaemia in Children
by: Riccardo Fiorentino, et al.
Published: (2021-08-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
by: S S Iyengar, et al.
Published: (2020-01-01)

Differential management and associations of dyslipidaemia and hypertension by glycaemic status in urban South Africans
by: N Peer, et al.
Published: (2024-03-01)

Dyslipidaemias in the elderly and the very old: gender differences
by: E. V. Tereshina, et al.
Published: (2013-03-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
by: Saxena S, et al.
Published: (2015-07-01)

Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism
by: Diego Daniel Miceli, et al.
Published: (2018-05-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
by: Tiny Nair
Published: (2024-03-01)

Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy
by: Alessandro Colletti, et al.
Published: (2022-11-01)

Dyslipidaemia in a Black African diabetic population: burden, pattern and predictors
by: William Lumu, et al.
Published: (2017-11-01)

Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns
by: Michael Adeyemi Olamoyegun, et al.
Published: (2016-10-01)

Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study
by: Emanuela Orsi, et al.
Published: (2021-01-01)

Association of PM2.5 With blood lipids and dyslipidaemia in a rural population of north-western china
by: Kairong Wang, et al.
Published: (2022-10-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
by: Hamilton Domingos, et al.

A rare presentation of type 1 diabetes mellitus: Diabetic ketoacidosis with severe dyslipidaemia and eruptive xanthomas
by: Ochai Attai Ateko, et al.
Published: (2022-01-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
by: Di Liu, et al.
Published: (2018-08-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
by: Alberto Zambon
Published: (2020-04-01)

Effect of Flaxseed (<i>Linum usitatissimum</i> L.) Supplementation on Vascular Endothelial Cell Morphology and Function in Patients with Dyslipidaemia—A Preliminary Observation
by: Dominika Kanikowska, et al.
Published: (2022-07-01)

The association between serum lipids and risk of premature mortality in Latin America: a systematic review of population-based prospective cohort studies
by: Rodrigo M. Carrillo-Larco, et al.
Published: (2019-10-01)

Trends and determinants of prevalence, awareness, treatment and control of dyslipidaemia in canton of Geneva, 2005–2019: Potent statins are underused
by: Pedro Marques-Vidal, et al.
Published: (2023-09-01)

Anthropometric correlates of dyslipidaemia in various stages of chronic obstructive pulmonary disease
by: G. Leela Jaya Madhuri, et al.
Published: (2018-01-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
by: Sung-Bum Lee, et al.
Published: (2022-07-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
by: Alberico L. Catapano, et al.
Published: (2017-06-01)

ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients
by: Alicja E. Grzegorzewska, et al.
Published: (2018-11-01)